INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 183 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2014. The put-call ratio across all filers is 1.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,595,648 | +61.4% | 193,940 | -3.7% | 0.02% | +61.5% |
| Q2 2023 | $2,228,148 | -2.4% | 201,460 | +21.9% | 0.01% | -18.8% |
| Q2 2022 | $2,283,000 | -14.6% | 165,310 | +0.7% | 0.02% | 0.0% |
| Q1 2022 | $2,672,000 | +0.4% | 164,210 | +0.5% | 0.02% | +6.7% |
| Q4 2021 | $2,662,000 | +8487.1% | 163,385 | +81592.5% | 0.02% | +1400.0% |
| Q4 2014 | $31,000 | -86.9% | 200 | -80.0% | 0.00% | -90.0% |
| Q3 2014 | $237,000 | – | 1,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
| Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
| Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
| Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
| Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
| EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
| Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
| AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |